Testing a new system for treating atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests a new device that uses pulsed electric fields to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if this approach is safe and effective for people with AF that comes and goes or lasts for a short time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with symptomatic atrial fibrillation that either comes and goes or is persistent.
- You have tried at least one heart rhythm medication and it didn't work or you couldn't tolerate it.
- Your atrial fibrillation has not lasted continuously for more than 12 months.
- You have not had a stroke or other blood clot event in the past 6 months.
- You have not had a heart attack or heart procedure (like a stent) in the past 3 months.
- You have not had any prior surgery or ablation on the left upper chamber of your heart.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to deliver energy (FARAPULSE PFA system) to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if these new waveforms can safely and effectively stop AF symptoms and improve quality of life.
This study tests a new way to treat atrial fibrillation using targeted electrical pulses (pulsed field ablation) instead of heat or cold. The goal is to improve safety and outcomes for people with paroxysmal or persistent AF.
This trial tests a new procedure that uses pulsed electric fields to treat persistent atrial fibrillation, a type of irregular heartbeat. The goal is to see if this approach is safe and effective in restoring a normal heart rhythm.
This trial tests an investigational device that uses pulsed electric fields to precisely target and disable the tiny areas in the heart that cause irregular heartbeats. It's for people with intermittent (paroxysmal) atrial fibrillation who haven't been helped by medications.
This trial tests a new pulsed-field device used during an atrial fibrillation (AF) catheter ablation, aiming to improve safety and effectiveness. It’s for people who have AF and are planning an AF ablation procedure.
This trial tests a new method called pulsed field ablation to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to safely stop AF episodes by targeting specific areas in the heart, and may help people with paroxysmal (coming and going) or persistent AF who haven't had this procedure before.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.